HTG Molecular prices shares and warrants offering at combined price of $7.75

HTG Molecular Diagnostics announced the pricing of a public offering of an aggregate of 1,290,322 shares of its common stock, Series A-1 warrants to purchase up to 1,290,322 shares of common stock and Series A-2 warrants to purchase 1,290,322 shares of common stock, at a combined public offering price of $7.75 per share and accompanying warrants. The Series A-1 warrants will have an exercise price of $7.50 per share, will be exercisable immediately upon issuance and will expire five years from the date of issuance, and the Series A-2 warrants will have an exercise price of $7.50 per share, will be exercisable immediately upon issuance and will expire twenty-four months from the date of issuance. H.C. Wainwright is acting as the exclusive placement agent for the offering.